Episode 090: Prostate Cancer Series, Pt. 7- Treatment for Met. Castrate Resistant Prostate Cancer
The Fellow on Call: The Heme/Onc Podcast
00:00
Treatment Options for Metastatic Castrate-Resistant Prostate Cancer
This chapter discusses the various treatment options for metastatic castrate-resistant prostate cancer, including docetaxel, enzalutamide, and abiraterone with prednisone. It explores the pivotal phase 3 trials for these treatments, as well as the rationale for sequencing enzalutamide after abiraterone.
Transcript
Play full episode
